General Grant
This funding opportunity provides financial support to organizations in Delaware that are tackling the opioid crisis through treatment, prevention, and recovery initiatives.
The General Grant is administered as part of the Opioid Abatement Community Grant Program overseen by the Delaware Prescription Opioid Settlement Distribution Commission. This funding mechanism represents the program’s primary investment pathway for organizations addressing opioid and substance use disorders within the state. The Commission operates under a mandate to allocate opioid settlement funds responsibly, with a strong emphasis on evidence based, community driven solutions that expand treatment access, prevention strategies, and recovery support systems. The General Grant is specifically designed to support experienced organizations capable of delivering measurable outcomes at scale. The purpose of this grant is to fund initiatives that directly combat the opioid crisis through clinical services, harm reduction strategies, prevention programs, and long term recovery infrastructure. Awards are intended for medium to large scale projects requiring significant financial investment, with funding amounts starting at 30000 dollars or more. Projects may span a performance period of up to two years, allowing grantees sufficient time to implement, evaluate, and refine interventions. Funding must align with approved uses under the settlement agreement and cannot replace existing funding sources, ensuring that all awarded funds supplement rather than supplant current efforts. Eligible applicants include legally registered entities operating within Delaware, such as nonprofit organizations, for profit entities, and governmental bodies. Organizations must demonstrate at least two years of operational history and provide evidence of prior successful program implementation. Applicants are required to show strong governance structures, qualified staffing, and financial stability, including the ability to manage large scale funding and comply with detailed reporting requirements. Emphasis is placed on organizations that can demonstrate alignment with statewide priorities and a commitment to equity, particularly in serving underserved or high risk populations. The application process is conducted exclusively through an online portal and requires submission of a comprehensive set of documents. These include organizational legal documentation, financial statements, a detailed project budget, compliance forms, and letters of support from community stakeholders. Applicants must also complete all required application fields and adhere strictly to submission guidelines. Failure to provide required documentation may result in disqualification, although a short cure period may be granted during initial review for missing materials. Applications undergo a multi phase evaluation process beginning with a technical compliance review to ensure completeness and alignment with statutory requirements. Qualified applications proceed to a scoring phase where multiple reviewers independently assess proposals using a standardized rubric. Final decisions incorporate both evaluation scores and strategic considerations such as geographic need and population impact. The Commission ultimately approves awards through a formal voting process. The current grant cycle opened on July 1, 2026, and applications are due by August 12, 2026. Following review, funding decisions are scheduled for September 28, 2026. Throughout the grant period, recipients must comply with ongoing reporting requirements, including performance metrics and financial tracking, as well as participation in site visits and technical assistance activities. This structured oversight ensures accountability and supports continuous program improvement. This grant is expected to recur as part of ongoing opioid settlement fund distribution, with future cycles likely following a similar annual timeline. Organizations are encouraged to prepare early, align proposals with strategic priorities, and demonstrate both programmatic effectiveness and long term sustainability. The General Grant plays a critical role in advancing Delaware’s coordinated response to the opioid epidemic by supporting impactful, data driven interventions across the state.
Award Range
$30,000 - Not specified
Total Program Funding
Not specified
Number of Awards
Not specified
Matching Requirement
No
Additional Details
Minimum awards of 30000 dollars or more; performance period up to two years
Eligible Applicants
Additional Requirements
Eligible applicants must be legally registered entities operating in Delaware, including nonprofits, for profit organizations, and governmental bodies, with at least two years of operational history, demonstrated financial stability, strong governance, and the capacity to deliver evidence based opioid related programs.
Geographic Eligibility
All
Ensure strong alignment with statewide priorities demonstrate evidence based approaches provide complete documentation and emphasize measurable impact
Application Opens
July 1, 2026
Application Closes
August 12, 2026
Grantor
Delaware Prescription Opioid Settlement Distribution Commission
Subscribe to view contact details

